Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Aytu BioPharma Stock (NASDAQ: AYTU) stock price, news, charts, stock research, profile.
Open1.566 | Close1.620 |
Vol / Avg.12.014K / 30.952K | Mkt Cap8.948M |
Day Range1.550 - 1.640 | 52 Wk Range1.380 - 4.880 |
Q1 2024 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.950 | (EXPECTED) 2023-09-27 | |||||
REV | 27.690M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-09 | Maxim Group | Naz Rahman | Initiates Coverage On | Buy | Announces | - | 5.00 |
2023-05-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 20.00 |
2022-07-21 | HC Wainwright & Co. | Vernon Bernardino | Maintains | Buy | Lowers | 11.00 | 6.00 |
2022-05-17 | Cantor Fitzgerald | Jennifer Kim | Maintains | Overweight | Lowers | 11.00 | 5.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
AYTU | Aytu BioPharma | 4.52% | 8.9M |
CING | Cingulate | -3.89% | 12M |
ITRM | Iterum Therapeutics | -8.33% | 8.6M |
CALC | CalciMedica | 1.9% | 15.2M |
JAGX | Jaguar Health | -3.57% | 5.2M |
You can purchase shares of Aytu BioPharma (NASDAQ: AYTU) through any online brokerage.
Other companies in Aytu BioPharma’s space includes: Cingulate (NASDAQ:CING), Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX) and Palisade Bio (NASDAQ:PALI).
The latest price target for Aytu BioPharma (NASDAQ: AYTU) was reported by Maxim Group on Wednesday, August 9, 2023. The analyst firm set a price target for 5.00 expecting AYTU to rise to within 12 months (a possible 208.64% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aytu BioPharma (NASDAQ: AYTU) is $1.62 last updated Today at September 25, 2023 at 8:00 PM UTC.
There is no dividend information for Aytu BioPharma.
Aytu BioPharma’s Q1 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Aytu BioPharma.
Aytu BioPharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.